McDermott Will & Schulte, a global law firm

Caitlyn M. Campbell, a former US Securities & Exchange Commission (SEC) Enforcement Attorney, co-leads the firm's SEC enforcement practice. She represents clients in SEC investigations, securities class action and derivative litigation and compliance matters. With more than two decades of experience in public service and private practice, Caitlyn advises on complex issues involving alleged violations of federal securities laws, including accounting fraud, disclosure and internal controls-related violations, regulatory violations by investment advisers and broker-dealers, insider trading, market abuse, anti-corruption and Foreign Corrupt Practices Act (FCPA) violations and whistleblower claims. She also assists companies in developing training programs and compliance policies and procedures.

Before joining McDermott Will & Schulte, Caitlyn served eight years at the SEC, including as Senior Counsel to the Directors of Enforcement, assisting with the management of the Commission’s largest division. At the SEC, Caitlyn led all aspects of investigations involving accounting fraud, complex insider trading schemes, market abuse, market manipulation, misappropriation of investor funds, investment adviser fraud and the Immigrant Investor Program. She also coordinated complex, cross-border investigations with foreign regulators. In addition to her investigative work, Caitlyn co-chaired the New England region committee that focused on proactively identifying accounting and disclosure fraud and served as liaison to both the SEC's national Financial Reporting and Audit Group and the Boston FBI.

Caitlyn has conducted numerous internal investigations for major public companies, their boards of directors, and board committees.  She has represented public companies, audit firms, senior executives, registered investment advisers, hedge funds and private equity firms in matters before the SEC, US Department of Justice (DOJ), and the Financial Industry Regulatory Authority (FINRA). Her litigation experience includes representing corporations, directors, and officers in securities class actions and shareholder derivative suits. She has also advised clients in Special Purpose Acquisition Company (SPAC)-related litigation and SEC investigations.

A frequent speaker on enforcement, accounting fraud, and internal investigations, Caitlyn is recognized for her deep understanding of the intersection between regulatory expectations and corporate governance.

Jiayan Chen is an industry leader on matters relating to health data, technology and research. She represents clients on regulatory and compliance matters, commercial transactions, and investments and acquisitions that require deep knowledge of privacy, data strategies, artificial intelligence (AI) and other healthcare technologies, or research compliance. Clients turn to Jiayan for her practical, industry-informed guidance as they seek to develop, improve, deploy, or acquire solutions or businesses that harness the power of data or technology. Jiayan has extensive experience advising on investments and acquisitions in the life sciences sector, particularly with respect to businesses that conduct clinical research or offer solutions designed to accelerate research or research recruitment. Her practice includes working with patient safety organizations (PSOs) on listing applications, compliance, and strategies for appropriately creating and sharing patient safety work product.

Jiayan’s subject matter and industry insights come from advising a broad range of clients, including AI and other healthcare technology companies; data companies; hospitals and health systems; academic medical centers; genetics companies; digital health companies; PSOs; drug, device, and biotech companies; private equity funds; and platform companies.

Jiayan regularly counsels clients on data privacy requirements under US federal and state privacy law, including the Health Insurance Portability and Accountability Act (HIPAA) and various state genetic, health information, and consumer privacy laws. She works with clients on mapping and implementing data use and sharing strategies with appropriate data governance and programmatic safeguards. Well before the proliferation of generative AI, Jiayan was working with AI developers and deployers on compliance with privacy and research laws, efforts to leverage data to train and validate AI tools, and transactions involving the licensing of AI tools and AI-enabled platforms. These days, Jiayan also guides clients in developing AI governance and advises on proposed regulatory and legislative changes impacting AI.

Jiayan represents clients on a wide array of matters related to biomedical research, including negotiating the full range of agreements impacting research, building research compliance infrastructure, preparing protocols and informed consent and authorizations, and conducting transactions involving research site networks, providers of research solutions and other stakeholders in the biomedical research space. Jiayan’s regulatory practice includes counseling clients on state and federal “sunshine” and gift ban laws. She analyzes proposed arrangements and corporate organizational structures to identify and inform reporting obligations, and helps clients develop compliance mechanisms for managing their reporting obligations.

Greg Heltzer, recognized by The Legal 500, named a Super Lawyers Rising Star, and rated a Thomson Reuters Stand-Out Lawyer, has extensive experience counseling clients on antitrust matters, with particular focus on transactional antitrust matters and mergers and acquisitions. Greg has successfully defended mergers for ABC Supply, Baxter, Constellation Brands, DaVita, JAB Partners, Mars, Martin Marietta Materials, Motorola Solutions, Olam, TreeHouse Foods, Worthington Industries, and many private equity firms among others.

His advice enables C-suite executives to assess the antitrust viability of potential transactions early, ensuring resources are not wasted on deals unlikely to gain clearance. When transactions move forward, he works closely with clients to streamline the regulatory review process, minimizing the burden of Second Requests and reducing potential delays.

Beyond merger clearance, Greg provides comprehensive antitrust guidance on issues such as information exchange, compliance programs, integration planning, Noerr-Pennington immunity, and interlocking directorates. He also has significant experience handling complex litigation and government investigations. In 2021, Greg was appointed by the Federal Trade Commission as an independent monitor to oversee the Decision and Order in the Matter of Corpus Christi Polymers LLC, et al.

Greg speaks and writes often on antitrust issues and has been nominated for several Antitrust Writing Awards by Concurrences, and won JD Supra's Top Author “Reader’s Choice” and Top Antitrust Blog for “Antitrust Alert,” which he founded and continues to manage.

Greg has broad industry knowledge developed through his representation of clients in numerous industries, including the following:

• Aerospace/Defense products (e.g., missiles, propulsion, simulation and training; aircraft)
• Agriculture, dairy, ingredients and food service equipment
• Alcohol (beer, wine and spirits)
• Aluminum and steel products
• Chemicals (industrial)
• Construction products and building supply (e.g., roofing, wallboard, insulation, lighting, aggregates, asphalt, cement)
• Consumer electronics
• Consumer products (branded and private label), including bars, meat products, dairy, ice cream, pudding, packaged food, pet food and treats, fragrances and cosmetics
• Distribution (e.g., MRO, building supply, food service)
• Energy (generation, transmission)
• Gift cards
• Health care services (dialysis, LASIK, eyeglass lenses), pharmaceuticals (animal and human), biometric solutions, laboratory and medical devices
• Medical technology (atrial fibrillation tools, spinal instruments)
• Packaging (e.g., flexible, paperboard)
• Physician practice groups
• Retail/chains (e.g., quick service restaurants, gas stations)
• Software (enterprise, institutional, communication/911) and other office products

Prior to joining the Firm, Greg served as a judicial law clerk for the Honorable John A. Terry of the DC Court of Appeals.

Sharon Lamb focuses her practice on transactional and regulatory advice in the health and life sciences sector and leads McDermott’s UK Health and Life Sciences Practice Group.

Sharon advises on global transactional mandates, including mergers and acquisitions and joint ventures in health services, pharma and life sciences, digital health and health technologies. Sharon also provides strategic, regulatory and commercial support to UK and international clients on UK health and life sciences with a focus on health services, pharmaceuticals, medical devices, digital health and health data.

Sharon is widely recognized for her expertise on NHS and public law procurement, regulatory and contracting matters, including payment and reimbursement and market access. She has particular experience advising strategic and private equity investors in transactions and investments in health and life sciences.

Sharon is also well-versed in health care services governance and regulatory matters, NHS public private partnerships, procurements, joint ventures and shared working arrangements, mergers, acquisitions, health data and competition issues.

Sharon has practiced health and life sciences law in the UK since 2002 and is recognized in Chambers and Legal 500. Sharon has written and lectures widely on health and life sciences issues and has a wealth of experience with NHS law and policy, having worked on a 4-year part time secondment with the NHS and national health bodies in London.

David J. Levine has more than 35 years of experience practicing international trade law. He counsels clients on import relief, customs, export controls, trade sanctions, anti-boycott, national security reviews of foreign investments and related trade laws and procedures. David advises and represents clients in antidumping and countervailing duty proceedings, trade controls and customs proceedings, national security (CFIUS) reviews of foreign investment in the US, trade compliance diligence in M&A transactions, trade-related legislative and rulemaking proceedings and trade negotiations.

Prior to joining the Firm, David was an international trade analyst with the US Department of Commerce (DOC) and a law clerk in the Office of the US Trade Representative.

Amol Parikh is a trusted advisor and courtroom advocate focused on intellectual property litigation, counseling, and procurement. Known for his ability to translate complex technical issues into winning legal strategies, Amol combines deep engineering knowledge with extensive trial and appellate experience to deliver results that align with his clients’ business goals. His work has earned consistent recognition, including the International Law Office’s prestigious “Client Choice Award” for Intellectual Property in Illinois— an honor based solely on nominations from corporate counsel for exceptional client service and measurable business impact.

Amol represents leading technology companies in high-stakes patent and trade secret disputes across US district courts, the International Trade Commission (ITC) and the Patent Trial and Appeal Board (PTAB). He is a results-driven advocate with experience spanning a broad spectrum of technologies, including Internet infrastructure, wireless communications, cybersecurity, semiconductor packaging, medical devices, power tools, high-resolution displays, computer and networking systems, mechanical devices, and business methods.

A registered patent attorney with a background in electrical engineering, Amol also manages preparation and prosecution of patent applications in cutting-edge fields such as digital and analog circuits, telecommunications systems, computer software and hardware, handwriting recognition-based software, wireless power devices, voice recognition and recordation software, semiconductor devices, artificial intelligence, medical devices, business methods, and financial products. He regularly handles inter partes review and ex parte reexamination proceedings before the US Patent and Trademark Office.

Beyond litigation and prosecution, Amol advises clients on comprehensive intellectual property asset management, including trade secret protection strategies and internal safeguards. He also conducts due diligence investigations and provides strategic counsel in connection with mergers, acquisitions, investments, and technology transactions. His work spans various industries, including health care solutions, autonomous driving, digital entertainment solutions, wireless communications, video conferencing, renewable energy sources, and medical devices, helping clients not only enforce their intellectual property rights but also proactively secure and maximize the value of their innovations.

Earlier in his career, Amol served as a judicial extern for the Honorable Amy J. St. Eve, District Judge of the Northern District of Illinois, and worked full-time as a technical specialist for an intellectual property law firm in Chicago. He was also a member of the DePaul Law Review. Prior to law school, he worked in the design and development of telecommunication systems at Hughes Network Systems.

Michael (Mike) Ryan advises manufacturers, healthcare providers, and investors on the legal, regulatory, and reimbursement/market access issues that arise during the development and commercialization of medical devices, clinical laboratory testing services, biological products, and drugs. He helps clinical laboratories and life sciences companies maintain regulatory compliance and evaluate, develop, and implement strategies to optimize coding, coverage, and payment for novel technologies.

Additionally, Mike helps innovative companies identify and navigate applicable Food and Drug Administration (FDA) regulatory requirements for new technologies, particularly in vitro diagnostics and digital health products. He regularly advises clients on the FDA’s evolving requirements for laboratory developed tests (LDTs) and reviews promotional and marketing materials for FDA-regulated medical products.

Mike also counsels clinical laboratories on state and federal compliance issues, including those under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), state laboratory licensure laws, and billing and reimbursement rules.

Thomas Sauermilch concentrates in cross-border mergers and acquisitions, joint ventures and other complex cross-border corporate/commercial transactions for major multinational corporations, private equity funds and their portfolio companies and medium-sized businesses. He also advises clients in corporate governance and compliance matters. He has led transactions in a wide range of sectors, including aerospace and avionics, automotive industries, chemicals, energy, engineering, food and beverage, manufacturing, media, medical devices and scientific instruments, metals and natural resources, packaging, pharmaceuticals, semiconductor equipment, software, technology and trading in North and South America, Europe and Asia. He has been recognized over many years by leading legal directories and nominated as Lawyer of the Year by The Deal (2018) and Dealmaker of the Year by M&A Advisor (2017). He has also been recognized as a BTI Client Service All-Star 2020 (BTI Consulting Group) and led the McDermott teams winning both the 2020 M&A Advisor Deal of the Year Awards in two categories (Cross-Border Deal of the Year and Materials Deal of the Year; $500million to $1billion) for Evonik Industries’ acquisition of PeroxyChem and the 2021 M&A Advisor Award for M&A Deal of the Year ($500million to $1billion) for Kaiser Aluminum’s acquisition of Alcoa Warrick. Thomas has held various leadership positions in the Firm, including former chair of its global M&A Practice and its Global Industrials Practice as well as a former member of the Firm’s Corporate Practice Leadership Team and its Management Committee.

To read Thomas' full biography in Japanese please click here.

Thomas is a former chair of the Firm’s Global M&A Practice.

Handles complex, global criminal and civil matters, including internal investigations, and investigations conducted by the Department of Justice

Focuses on healthcare enforcement and compliance, including False Claims Act, Anti-Kickback Statute, and Stark Law matters

Represents clients in antitrust criminal investigations and related class actions, and advises on global compliance programs

Has extensive experience with Japanese clients, including in global investigations and implementation and updating of global compliance programs

Brings extensive appellate experience, having served as lead appellate counsel in more than 100 cases in nearly all of the US courts of appeals and before the US Supreme Court

Handles pro bono litigation projects in a wide array of substantive areas, including civil rights, LGBTQ+ rights, children’s rights, disabilities’ rights, and immigration as the firm’s pro bono litigation partner

Dr. Boris Uphoff has 24 years of experience representing companies in both court and arbitration proceedings. His practice focuses on intellectual property disputes (patents, trademarks, unfair competition), product liability law, insurance law and D&O disputes.

Many of the disputes he handles are cross-jurisdictional and involve other European countries, the US or Japan. He represents national and international companies, particularly within the automotive, electronics, food and insurance sectors.

To read Boris' full biography in Japanese please click here.

He also regularly acts as an arbitrator in international arbitration proceedings.

Boris is admitted as a lawyer (Rechtsanwalt) in Germany and as a solicitor in England and Wales. He is a certified specialist in intellectual property law (Fachanwalt für gewerblichen Rechtsschutz) and acts as an honorary judge at the Lawyers’ Disciplinary Court (Anwaltsgericht) for the District of the Munich Bar.

Michael (Mike) Morgan is recognized as one of the nation’s leading lawyers in cybersecurity and data privacy. He has guided clients through some of the largest and most complex data breaches, breaches involving more than 50 million records, incidents affecting persons in over 100 countries around the world, and incidents involving sensitive defense-related information. He counsels clients on compliance with US and international regulations relating to cybersecurity and data privacy, including compliance with the California Consumer Privacy Act (CCPA), the EU’s General Data Protection Regulation (GDPR) and China’s Network Security Law. Mike leads the firm's Data, Privacy & Cybersecurity Group.

Mike has particular experience on complex legal issues arising from advanced technologies. He represents companies on privacy and cybersecurity issues arising from vehicle autonomy and connectivity and is an expert on the fast-changing regulatory environment relating to autonomous vehicles and in the US and around the world. He also advises clients on matters relating to international data transfers (e.g., EU model clauses and Privacy Shield), cryptocurrency, e-commerce security and blockchain applications. He represents clients in a range of industries, including financial services, big data, automotive, telecommunications, healthcare, insurance and automotive, as well as defense contractors and subcontractors subject to requirements under DFARS and the CMMC Framework.

Mike has handled scores of privacy and cybersecurity-related cases, including more than one hundred lawsuits involving claims under the Fair Credit Reporting Act (FCRA); unfair, deceptive or abusive acts and practice (UDAAP) statutes; and consumer protection statutes. He has particular expertise in the defense of cases involving claims for statutory damages and advises clients on mitigation of legal risks arising from the CCPA’s statutory damages provisions applicable to data breaches. He has defended against government investigations by the Federal Trade Commission, Consumer Financial Protection Bureau, Federal Communications Commission and state attorneys general. Mike is a Certified Information Privacy Professional (CIPP/US) by the International Association of Privacy Professionals (IAPP).